These are among the allegations the Anti-Corruption Branch (ACB) has mentioned in its chargesheet into the alleged Delhi government medical procurement scam, pegging the wrongful loss to the public exchequer at Rs 842 crore. The court has taken cognizance of the chargesheet.

The case centres on the Central Procurement Agency (CPA), the nodal agency responsible for supplying medicines, vaccines and medical equipment to Delhi government hospitals and healthcare facilities.

Filed on September 16, the chargesheet alleged that tenders were manipulated to favour two companies — F-Med Devices and M Sahib and Sons Private Limited — owned by pharmaceutical trader Rajiv Rangila (50).…